US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 1.060
  • 0.0000.00%
Close Mar 11 16:00 ET
  • 1.080
  • +0.020+1.88%
Post 16:38 ET
68.09MMarket Cap-0.65P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inozyme Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Inozyme Pharma Earnings Reports

  • Inozyme Pharma | 10-K: Annual report

    Mar 10 08:33 ET

  • Inozyme Pharma | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 08:36 ET

  • Inozyme Pharma | 8-K: Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights

    Nov 5, 2024 08:36 ET

  • Inozyme Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 08:43 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +4.51%
    New Fortress Energy
    NFE
    +3.12%
    Hutchmed (China)
    HCM
    +1.62%
    Collegium Pharmaceutical
    COLL
    +1.11%
    Dorian LPG
    LPG
    +0.20%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 11, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data